Status:
COMPLETED
Medicinal Nicotine for Preventing Stress Induced Craving and Withdrawal Symptoms
Lead Sponsor:
University of Minnesota
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Tobacco Use Disorder
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The purpose of this study is to determine the timeframe (relative to a stress task) that is most effective at attenuating the increase in symptoms of tobacco craving and withdrawal that occur when smo...
Eligibility Criteria
Inclusion
- Smoking an average of at least 10 cigarette per day
- General good health
Exclusion
- unstable medical or psychiatric conditions
- history of severe motion sickness
- women who are pregnant or breast feeding
- The investigators will evaluate if there are other reasons why someone may not participate
Key Trial Info
Start Date :
December 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2014
Estimated Enrollment :
98 Patients enrolled
Trial Details
Trial ID
NCT01522963
Start Date
December 1 2011
End Date
January 1 2014
Last Update
August 21 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical and Translational Sciences Institute
Minneapolis, Minnesota, United States, 55455